Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 11, Issue 5, Pages 453-456Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2011.07.009
Keywords
-
Categories
Funding
- Achaogen
- AstraZeneca
- Merck
Ask authors/readers for more resources
The widespread emergence of resistance to antimicrobial agents has taken mammoth dimension and warrants immediate steps to minimize it. Pharmacokinetics/pharmacodynamics of antimicrobial agents, differences among bacterial species, and time-dependent changes in the bacterial population are important factors involved in the development of drug resistance. The key to minimizing resistance lies in understanding how these factors affect resistance emergence and incorporating them in dosing regimen design. In vitro models have proven to be a valuable tool to study these factors and their contribution in resistance emergence. This review summarizes the key factors implicated in resistance development and the lessons learnt from in vitro studies optimizing antimicrobial dosing to prevent resistance emergence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available